ANANDA Scientific announces FDA approval of the IND for a clinical trial exploring treatment of Social Anxiety Disorder (SAD)

Read also

Nightmare bacteria

«Nightmare bacteria» cases on the rise in the US: CDC

NRx Pharmaceuticals

NRx Pharmaceuticals Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product

Akari Therapeutics

Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1

Breakthrough Therapy Designation To Povetacicept

Vertex: FDA Grants Breakthrough Therapy Designation To Povetacicept